• ARCHEXIN chembl:CHEMBL4298094 Antineoplastic

    Alternate Names:

    ARCHEXIN
    RX-0201
    RX-201

    Drug Info:

    FDA Approval not approved
    Drug Class antisense oligo
    Drug Indications antineoplastic agent
    Drug Type small molecule
    Drug Groups investigational
    (1 More Sources)

    Publications:

  • Interaction Score: 0.97

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Novel Target
    Trial Name RX-0201 ,Archexin
    combination therapy Everolimus + RX-0201

    PMIDs:
    None found


  • Interaction Score: 0.82

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name RX-0201,Archexin
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 0.76

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name RX-0201,Archexin
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

    • Version: 5.1.7

    Alternate Names:
    ARCHEXIN DrugBank Drug Name
    Archexin Drug Brand

    Drug Info:
    Drug Type small molecule
    Drug Groups investigational

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class antisense oligo
    FDA Approval not approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D07SYZ TTD Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:

    Drug Info:

    Publications: